Product
Chinese Herbal Medicine
2 clinical trials
2 indications
Indication
Hepatocellular CarcinomaClinical trial
A Real-world Study of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular CarcinomaStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
Feasibility, Safety, and Effectiveness of Chinese Herbal Medicine for T2DM Patients With Comorbid Metabolic Syndrome: A Single-arm Pilot StudyStatus: Not yet recruiting, Estimated PCD: 2024-09-01